✦ LIBER ✦

PCV21 ANTIHYPERTENSIVE DRUG BUDGET IMPACT OF THE ANGIOTENSIN II RECEPTOR BLOCKERS (ARB) IN THE UK

✍ Scribed by BT Blak; MR Weir; L Simoni-Wastila; FT Shaya; CE Cooke; CD Mullins

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Comparative meta-analysis of the antihyp

✍ Kathleen A. Packard; Richard L. Wurdeman; Daniel E. Hilleman; Syed M. Mohiuddin; 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 38 KB

PCV63 ECONOMIC IMPACT OF SWITCHING FROM

✍ J Signorovitch; J Zhang; EQ Wu; D Latremouille-Viau; AP Yu; H Dastani; KH Kahler 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

Prescribing Trends and Drug Budget Impac

✍ Betina T. Blak; C. Daniel Mullins; Fadia T. Shaya; Linda Simoni-Wastila; Catheri 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

HP2 TRENDS IN ANGIOTENSIN II RECEPTOR BL

✍ BT Blak; CD Mullins; L Simoni-Wastila; FT Shaya; CE Cooke; MR Weir 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Angiotensin-converting enzyme inhibitors

✍ Hilda J. I. de Jong; Rob J. Vandebriel; Siti R. F. Saldi; Liset van Dijk; Henk v 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB

PCV86 INSURANCE STATUS AND THE USE OF AN

✍ N. Kaisaeng; J. Zhang 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB